Syneos Health Names Michelle Keefe as Next Chief Executive O

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Michelle Keefe as CEO and a member of the Company’s Board of Directors. Keefe, currently President, Medical Affairs and Commercial Solutions, succeeds Alistair Macdonald, who will ...

Related Keywords

Alistair Macdonald , John Dineen , Michael Brooks , Michelle Keefe , Prior To Syneos Health , Seton Hall University , Nurse Service , Global Head Of Clinical Development , Nasdaq , Global Group , Pfizer , Carolina State University , Clinical Development , Health Sciences , Company Reports First Quarter , Publicis Health , Company Investor Relations , Company Board Of Directors , Syneos Health Board Of Directors , Contract Sales Organization , Syneos Health , Global Head Of Clinical Development Solutions , Syneos Health Dei Council , Retire After , Reports First Quarter , Updates Full Year , Medical Affairs , Commercial Solutions , Full Service Commercial , Syneos One , Global Group President , Chief Development Officer , Regional President , Visiting Nurse Service , Seton Hall , Syneos Health Board , Chief Operating Officer , Global Head , Clinical Development Solutions , Commercialization Services , Executive Vice President , North Carolina State , Investor Relations ,